American Portfolios Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-50
| Closed | -$4.65K | – | 3685 |
|
|
2021
Q4 | $4.65K | Hold |
50
| – | – | ﹤0.01% | 2922 |
|
|
2021
Q3 | $2.98K | Hold |
50
| – | – | ﹤0.01% | 3042 |
|
|
2021
Q2 | $3.41K | Hold |
50
| – | – | ﹤0.01% | 2974 |
|
|
2021
Q1 | $3.47K | Sell |
50
-627
| -93% | -$48.2K | ﹤0.01% | 2828 |
|
|
2020
Q4 | $52K | Buy |
677
+78
| +13% | +$5.85K | ﹤0.01% | 1401 |
|
|
2020
Q3 | $44.8K | Buy |
599
+200
| +50% | +$13.3K | ﹤0.01% | 1358 |
|
|
2020
Q2 | $25.1K | Buy |
399
+349
| +698% | +$19.2K | ﹤0.01% | 1553 |
|
|
2020
Q1 | $2.1K | Sell |
50
-20
| -29% | -$917 | ﹤0.01% | 2386 |
|
|
2019
Q4 | $3.18K | Sell |
70
-650
| -90% | -$30.7K | ﹤0.01% | 2433 |
|
|
2019
Q3 | $33K | Hold |
720
| – | – | ﹤0.01% | 1465 |
|
|
2019
Q2 | $42.2K | Hold |
720
| – | – | ﹤0.01% | 1345 |
|
|
2019
Q1 | $32.3K | Hold |
720
| – | – | ﹤0.01% | 1383 |
|
|
2018
Q4 | $28K | Buy |
720
+50
| +7% | +$1.96K | ﹤0.01% | 1250 |
|
|
2018
Q3 | $30.8K | Hold |
670
| – | – | ﹤0.01% | 1319 |
|
|
2018
Q2 | $29.2K | Hold |
670
| – | – | ﹤0.01% | 1300 |
|
|
2018
Q1 | $26.5K | Buy |
670
+300
| +81% | +$11.7K | ﹤0.01% | 1283 |
|
|
2017
Q4 | $12.6K | Buy |
+370
| New | +$10.5K | ﹤0.01% | 1496 |
|
American Portfolios Advisors's ARNA Position: Q1 2022 in Review
American Portfolios Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 50 shares — an estimated $4.65K sold.
American Portfolios Advisors first reported a position in ARNA in Q4 2017 and held it in 17 quarters. The position peaked at $52K in Q4 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- American Portfolios Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- American Portfolios Advisors sold 50 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $4.65K.
- American Portfolios Advisors first reported a position in Arena Pharmaceuticals Inc in Q4 2017 and held it in 17 quarters.
- American Portfolios Advisors's Arena Pharmaceuticals Inc position peaked at $52K in Q4 2020.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on American Portfolios Advisors's 13F filing for Q1 2022, filed 21 Mar 2023.